Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• CappettaALonardiSPastorelliDBergamoFLombardiGZagonelVAdvanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapiesCrit Rev Oncol Hematol2012811384821256046
   PubMed Web of Science ®Google Scholar
• YangWRaufiAKlempnerSJTargeted therapy for gastric cancer: molecular pathways and ongoing investigationsBiochim Biophys Acta20141846123223724858418
   PubMed Web of Science ®Google Scholar
• CunninghamDAllumWHStenningSPPerioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerN Engl J Med20063551112016822992
   PubMed Web of Science ®Google Scholar
• ShammaRNAburahmaMHFollicular delivery of spironolactone via nanostructured lipid carriers for management of alopeciaInt J Nanomedicine201495449546025473283
   PubMed Web of Science ®Google Scholar
• YangXYLiYXLiMZhangLFengLXZhangNHyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancerCancer Lett2013334233834522776563
   PubMed Web of Science ®Google Scholar
• LuanJZhangDHaoLPreparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriersColloids Surf B Biointerfaces201411425526024211416
   PubMed Web of Science ®Google Scholar
• MuraSBuiDTCouvreurPNicolasJLipid prodrug nanocarriers in cancer therapyJ Control Release2015208254125617724
   PubMed Web of Science ®Google Scholar
• NegiLMTalegaonkarSJaggiMSurface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigationColloids Surf B Biointerfaces201412360060925454761
   PubMed Web of Science ®Google Scholar
• ChoHJYoonHYKooHSelf-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxelBiomaterials2011322971817190
   Web of Science ®Google Scholar
• HanHSLeeJKimHRRobust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivoJ Control Release2013168210511423474029
   PubMed Web of Science ®Google Scholar
• GhaffarzadehganKJafarzadehMRazieeHRExpression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importanceWorld J Gastroenterol200814416376638119009655
   PubMed Web of Science ®Google Scholar
• WangDRChenGYLiuXLCD44v6 in peripheralblood and bone marrow of patients with gastric cancer as micro-metastasisWorld J Gastroenterol2006121364216440414
   PubMed Web of Science ®Google Scholar
• AghcheliKParsianHQujeqDSerum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancersEur J Intern Med2012231586422153533
   PubMed Web of Science ®Google Scholar
• YaoHJZhangYGSunLLiuYThe effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cellsBiomaterials201435339208922325115788
   PubMed Web of Science ®Google Scholar
• Gomez-MartínCLopez-RiosFAparicioJA critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyondCancer Lett20143511304024943493
   PubMed Web of Science ®Google Scholar
• BokuNYamamotoSFukudaHFluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomized phase 3 studyLancet Oncol200910111063106919818685
   PubMed Web of Science ®Google Scholar
• BangYJVan CutsemEFeyereislovaATrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trialLancet2010376974268769720728210
   PubMed Web of Science ®Google Scholar
• CervantesARodaDTarazonaNRosellóSPérez-FidalgoJACurrent questions for the treatment of advanced gastric cancerCancer Treat Rev2013391606723102520
   PubMed Web of Science ®Google Scholar
• Di PaoloADanesiRFalconeARelationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patientsAnn Oncol20011291301130611697844
   PubMed Web of Science ®Google Scholar
• GiorgioECarotiCMattioliFSevere fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluationCancer Chemother Pharmacol20116851355136121833589
   PubMed Web of Science ®Google Scholar
• AshwanikumarNKumarNANairSAKumarGS5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticlesActa Biomater201410114685469425110286
   PubMed Web of Science ®Google Scholar
• van KuilenburgABDihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracilEur J Cancer200440793995015093568
   PubMed Web of Science ®Google Scholar
• ContinoCMaurizisJCPucciBSynthesis and preliminary biological assessments of a new class of amphiphilic telomers bearing 5-fluorouracil moietiesMacromol Chem Phys1999200613511355
   Web of Science ®Google Scholar
• NichiforMSchachtEHSeymourLWPolymeric prodrugs of 5-fluorouracilJ Control Release1997482–3165178
   Web of Science ®Google Scholar
• CuiSXZhangHLXuWFQuXJ13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13)Eur J Pharmacol2014734505924726845
   PubMed Web of Science ®Google Scholar
• ThomasAMKapanenAIHareJIDevelopment of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacyJ Control Release2011150221221921094191
   PubMed Web of Science ®Google Scholar
• GhasemiZDinarvandRMottaghitalabFEsfandyari-ManeshMSayariEAtyabiFAptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomasCarbohydr Polym201512119019825659689
   PubMed Web of Science ®Google Scholar
• LiQDuYZYuanHSynthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery systemEur J Pharm Sci2010413–449850720728535
   PubMed Web of Science ®Google Scholar
• ZhuSWongananPLansakara-PDSO’MaryHLLiYCuiZThe effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpressionBiomaterials20133492327233923261218
   PubMed Web of Science ®Google Scholar
• YuBTSunXZhangZREnhanced liver targeting by synthesis of N1-stearyl-5-Fu and incorporation into solid lipid nanoparticlesArch Pharm Res2003261096110114723346
   PubMed Web of Science ®Google Scholar
• RautioJKumpulainenHHeimbachTProdrugs: design and clinical applicationsNat Rev Drug Discov20087325527018219308
   PubMed Web of Science ®Google Scholar
• PablaNDongZCisplatin nephrotoxicity: mechanisms and renoprotective strategiesKidney Int2008739994100718272962
   PubMed Web of Science ®Google Scholar
• SenguptaPBasuSSoniSCholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicityProc Natl Acad Sci U S A201210928112941129922733767
   PubMed Web of Science ®Google Scholar
• GuoSMiaoLWangYHuangLUnmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapyJ Control Release201417413714224280262
   PubMed Web of Science ®Google Scholar
• WangYZhouJQiuLCisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cellsBiomaterials201435144297430924565522
   PubMed Web of Science ®Google Scholar
• LiuZRimmerSSynthesis and release of 5-fluorouracil from poly(N-vinylpyrrolidinone) bearing 5-fluorouracil derivativesJ Control Release2002811–2919911992682
   PubMed Web of Science ®Google Scholar
• FarshoriNNBandayMRZahoorZRaufADCC/DMAP mediated esterification of hydroxy and non-hydroxy olefinic fatty acids with β-sitosterol: in vitro antimicrobial activityChin Chem Lett2010216646650
   Web of Science ®Google Scholar
• FanXChenJShenQDocetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal deliveryInt J Pharm2013458229630424177313
   PubMed Web of Science ®Google Scholar
• LuanJZhangDHaoLPreparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriersColloids Surf B Biointerfaces201411425526024211416
   PubMed Web of Science ®Google Scholar
• AvgoustakisKBeletsiAPanagiZKlepetsanisPKarydasAGIthakissiosDSPLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood propertiesJ Control Release2002791–312313511853924
   PubMed Web of Science ®Google Scholar
• ChouTCTheoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studiesPharmacol Rev200658362168116968952
   PubMed Web of Science ®Google Scholar
• YanLHWeiWYCaoWLZhangXSXieYBXiaoQOverexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistanceAm J Cancer Res20145132133225628941
   PubMed Web of Science ®Google Scholar
• FataFRonIGKemenyNO’ReillyEKlimstraDKelsenDP5-Fluorouracil-induced small bowel toxicity in patients with colorectal carcinomaCancer1999861129113410506695
   PubMed Web of Science ®Google Scholar
• AshwanikumarNKumarNANairSAKumarGSVMethacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colonInt J Nanomedicine201275769577923172988
   PubMed Web of Science ®Google Scholar
• LiuZRimmerSSynthesis and release of 5-fluorouracil from poly (N-vinylpyrrolidinone) bearing 5-fluorouracil derivativesJ Control Release200281919911992682
   PubMed Web of Science ®Google Scholar
• PlattVMSzokaFCAnticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptorMol Pharmacol200854474486
   PubMedGoogle Scholar
• PeerDMargalitRLoading mitomycin C inside long circulation hyaluronan targeting nano-liposomes increases its antitumor activity in three mice tumor modelsInt J Cancer200410878078914696107
   PubMed Web of Science ®Google Scholar
• MizrahySRazSRHasgaardMHyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune responseJ Control Release201115623123821745506
   PubMed Web of Science ®Google Scholar
• HanYZhangYLiDChenYSunJKongFTransferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicinInt J Nanomedicine201494107411625187713
   PubMed Web of Science ®Google Scholar
• Harush-FrenkelORozenturEBenitaSAltschulerYSurface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cellsBiomacromolecules20089243544318189360
   PubMed Web of Science ®Google Scholar
• ZhaoLWientjesMGAuJLEvaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analysesClin Cancer Res200410237994800415585635
   PubMed Web of Science ®Google Scholar
• FengTTianHXuCSynergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatmentEur J Pharm Biopharm20148831086109325305583
   PubMed Web of Science ®Google Scholar